Clearpoint Neuro Inc (CLPT) Directors and Executive Officers - CSIMarket
CSIMarket
 
Clearpoint Neuro Inc   (NASDAQ: CLPT)

Clearpoint Neuro Inc

Officers & Directors


R. John Fletcher
Chairman and Director

Timothy T. Richards
Director

Matthew B. Klein
Director

Pascal E.R. Girin
Director

Joseph M. Burnett
Chief Executive Officer and President (Principal Executive Officer)

Danilo D Alessandro
Chief Financial Officer

Lynnette C. Fallon
Director

Linda M. Liau
Director

B. Kristine Johnson
Director

Cherry Bekaert LLP
Auditors since - ,

Clearpoint Neuro Inc currently has 172 employees.

  News about Clearpoint Neuro Inc Key Personnel

ClearPoint Neuro Achieves Debt-Free Status with Early Repayment of $10 Million Note,

ClearPoint Neuro Achieves Debt-Free Status with Early Repayment of $10 Million Note
ClearPoint Neuro, a leading therapeutic neuro-navigation system provider, has made a significant stride towards improving its financial health by announcing the early repayment of a $10 million convertible note, held by PTC Therapeutics. This repayment marks a pivotal moment for ClearPoint Neuro as it successfully clears all debt from its balance sheet.
The early repayment of the principal and interest on the $10 million note held by PTC Therapeutics is a testament to ClearPoint Neuro s commitment to enhancing its financial position and securing a solid footing for future growth. By eliminating this debt, the company ...






CLPT Management Effectiveness CLPT Revenue per Employee CLPT Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.